Description
購入する Somatropin 日本のボディビルショップで、世界中に配送します。クレジットカードのご利用が可能です。 MasterCard, Visa, AmEx およびPayPal決済が可能です。
テスト ハイクオリティ Human Growth Hormone オンライン販売. Maxtreme Pharma’s Soma-Max-10 が最高品質 Human Growth Hormone 100IU 10 バイアル of 10IU (Somatropin) from famous Hormones & Peptides producer.
Our online pharmacy delivers Hormones & Peptides worldwide, so we can ship your order to you fast, safe and discreet no matter where you live: アメリカ、カナダ、イギリス、アイルランド、スペイン、ドイツ、フランス、イタリア、オランダ、南アフリカ、デンマーク、スウェーデン、フィンランド、ノルウェー、日本、ニュージーランド、その他. また、紛失、押収、破損した小包の再発送も承っております。
アメリカ、カナダ、イギリス、アイルランド、スペイン、ドイツ、フランス、イタリア、オランダ、南アフリカ、デンマーク、スウェーデン、フィンランド、ノルウェー、日本、ニュージーランド、その他. また、紛失、押収、破損した小包の再発送も承っております。 ステロイド販売 を、お客さまに安心してお使いいただけます。
私たちのフレンドリーなスタッフがいつでもお手伝いします。 すべての荷物にトラッキングコードがついています. ご注文の状況をメールでお知らせするほか、専用のオンラインサービスで現在の状況を常に確認することができます。
Soma-Max-10 というのが広く知られている Somatropin, Somatotropin, Humatrope
の他の別称。 Soma-Max-10 (Human Growth Hormone): Maxtreme Pharma, Human Growth Hormone, HGH, Human Growth Hormone, HGH, Somatropin 100IU バイアル of 10IU, Soma-Max-10 100IU バイアル of 10IU.
これらはすべて、同じ活性物質の異なるブランドである – Human Growth Hormone
Soma-Max – Somatropin For Injection (Lyophilized)
Somatropin (as well as endogenous GH) binds to a dimeric GH receptor in the cell membrane of target cells resulting in intracellular signal transduction and a host of pharmacodynamic effects. Some of these pharmacodynamic effects are primarily mediated by IGF-1 produced in the liver and also locally (e.g., skeletal growth, protein synthesis), while others are primarily a consequence of the direct effects of somatropin (e.g., lipolysis)
INDICATION
Pediatric Patients
- (somatropin [rDNA origin] injection) is indicated for the treatment of children with growth failure due to inadequate secretion of endogenous growth hormone (GH).
- [somatropin (rDNA origin) injection] is indicated for the treatment of pediatric patients who have growth failure due to Prader-Willi Syndrome (PWS). The diagnosis of PWS should be confirmed by appropriate genetic testing
- [somatropin (rDNA origin) injection] is indicated for the treatment of growth failure in children born small for gestational age (SGA) who fail to manifest catch-up growth by age 2 years.
- [somatropin (rDNA origin) injection] is indicated for the treatment of growth failure associated with Turner syndrome.
- (somatropin [rDNA origin] injection) is indicated for the treatment of idiopathic short stature (ISS), also called non-growth hormone-deficient short stature, defined by height standard deviation score (SDS) ≤ -2.25, and associated with growth rates unlikely to permit attainment of adult height in the normal range, in pediatric patients whose epiphyses are not closed and for whom diagnostic evaluation excludes other causes associated with short stature that should be observed or treated by other means.
Adult Patients
- (somatropin [rDNA origin] injection) is indicated for the replacement of endogenous GH in adults with growth hormone deficiency (GHD) who meet either of the following two criteria:
- Adult Onset (AO): Patients who have GHD, either alone or associated with multiple hormone deficiencies (hypopituitarism), as a result of pituitary disease, hypothalamic disease, surgery, radiation therapy, or trauma; or
- Childhood Onset (CO): Patients who were GH deficient during childhood as a result of congenital, genetic, acquired, or idiopathic causes.
Patients who were treated with somatropin for growth hormone deficiency in childhood and whose epiphyses are closed should be reevaluated before continuation of somatropin therapy at the reduced dose level recommended for growth hormone deficient adults. Confirmation of the diagnosis of adult growth hormone deficiency in both groups involves an appropriate growth hormone provocative test with two exceptions: (1) patients with multiple other pituitary hormone deficiencies due to organic disease; and (2) patients with congenital/genetic growth hormone deficiency.
